Aliada Therapeutics
Steven Sweeney is an experienced executive in the biotechnology and pharmaceutical sectors. Currently serving as President and Chief Operating Officer of Aliada Therapeutics, Sweeney previously held the positions of President and CEO at Integrity Clinical Services, LLC, and Executive Vice President of Clinical Development Operations at Third Harmonic Bio, where Sweeney also served as Senior Vice President of Clinical Development Operations. Additional experience includes a role as Entrepreneur In Residence at Atlas Venture and Vice President at Rodin Therapeutics, which was later acquired by Alkermes.
This person is not in any teams
This person is not in any offices
Aliada Therapeutics
Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases. Its platform applies its technology to specific CNS target antibody binders and progress programs through preclinical evaluation to help medical professionals treat CNS diseases.The company was founded in 2021 and is headquarteredin Boston, Massachusetts.